Ligand validation:8GBT

SAC: N-ACETYL-SERINE

SAC is a Ligand Of Interest in 8GBT designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8GBT_SAC_I_102	2%	58%	0.403	0.684	0.55	1.06	-	1	1	0	90%	0.9
8GBT_SAC_V_101	0%	61%	0.643	0.541	0.55	0.94	-	1	0	0	90%	0.9
8GCQ_SAC_V_102	8%	51%	0.333	0.818	0.52	1.36	-	1	1	0	90%	0.9
7THU_SAC_I_101	3%	59%	0.336	0.677	0.52	1.04	-	1	2	0	90%	0.9
7TIE_SAC_I_101	0%	60%	0.368	0.315	0.62	0.89	-	-	2	0	90%	0.9
7TIH_SAC_I_101	0%	54%	0.407	0.274	0.54	1.21	-	1	0	0	90%	0.9
7TII_SAC_V_101	0%	62%	0.493	0.315	0.52	0.92	-	1	1	0	90%	0.9
9FDD_SAC_G_401	67%	62%	0.172	0.983	0.84	0.61	-	-	0	0	100%	1
9F14_SAC_A_401	66%	58%	0.168	0.975	0.7	0.9	-	-	0	0	100%	1
4M4G_SAC_A_401	38%	8%	0.213	0.915	1.94	2.59	2	5	0	0	100%	1
4UFA_SAC_A_1301	27%	30%	0.185	0.848	1.21	1.56	1	2	4	0	90%	0.9

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.